A phase I single dose escalation trial of ch806 in patients with advanced tumours expressing the 806 antigen
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2006
At a glance
- Drugs Indium 111 ABT 806 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 09 Aug 2006 New trial record.